Chlor-Trimeton

Quick links to important sections

Chlor-Trimeton

Selected form

Treatment option: Fever, Hay Fever

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chlor-Trimeton

Quick Facts

Property Description
Active Ingredient Chlorpheniramine maleate (Chlorphenamine)
Form Tablet, Syrup, Oral Solution, Injection
Pharmacological Class First-Generation Antihistamine
Common Use Symptomatic relief of allergic conditions
Origin Synthetic

Chlor-Trimeton: Definition and Pharmacological Classification

Chlor-Trimeton is a recognized trade name for a medication whose active component is chlorpheniramine maleate, a synthetic compound utilized primarily for allergy relief. This medicine is structurally defined as a first-generation antihistamine, belonging to the larger chemical group of alkylamine derivatives. This substance is classified as an Antihistamine active ingredient.

As an antihistamine, it functions as a Histamine H1-receptor antagonist. This established mechanism means the drug counteracts the effects of histamine, a chemical released by the body that triggers allergic reactions. Chlorpheniramine is clinically recognized for its rapid onset of action in providing relief. It is considered an effective, low-cost option among H1-receptor blockers for acute allergy relief and is a standard treatment for easing acute allergic discomfort.

Composition, Forms, and General Therapeutic Purpose

The core composition of this product, when sold as a monotherapy, is the single-ingredient active substance, chlorpheniramine maleate. This substance is formulated into various dosage forms to accommodate patient needs, including the common tablet, syrup, and oral solution. Chlor-Trimeton is available in these different physical formats for administration.

Because the drug is often available over-the-counter (OTC), its general therapeutic purpose is the symptomatic relief of allergic conditions. By functioning as an H1 antagonist, the drug prevents the binding of histamine, thereby mitigating the overall physical discomfort associated with the hypersensitivity response.

What side effects are possible with Chlor-Trimeton?

Possible side effects and safety information

The safety profile for Chlor-Trimeton (chlorpheniramine maleate) is officially documented by government regulatory agencies and is characterized primarily by its effects on the central nervous system and its anticholinergic properties.

Frequency-Classified Adverse Reactions

Adverse reactions are classified by frequency as listed in regulatory documents:

Classification Examples of Reactions (System-Organ Class)
Very Common / Common Drowsiness, Sedation (Nervous System); Dry mouth (Gastrointestinal); Dizziness, Blurred vision.
Uncommon Confusion, Restlessness, Excitation/Nervousness, Tinnitus (Ear and Labyrinth).
Rare / Very Rare Tachycardia, Hypotension (Cardiovascular/Vascular); Convulsions, Severe blood disorders (Blood and Lymphatic System Disorders, e.g., Agranulocytosis).

Serious and Population-Specific Safety Notes

The official labeling documents rare but serious adverse reactions, including severe blood dyscrasias like aplastic anemia and agranulocytosis, which are considered clinically significant events. The potential for severe, systemic allergic reactions (anaphylaxis) is also documented in the safety profile.

Specific safety considerations exist for certain groups. Regulatory documents state that older adults are generally more susceptible to Central Nervous System (CNS) side effects such as pronounced sedation, dizziness, and confusion. Conversely, in some pediatric patients, paradoxical reactions like excitement and restlessness may occur.

Safety-Related Restrictions

Official labeling mandates a restriction against concomitant use with other CNS depressants (including alcohol, sedatives, and tranquilizers) due to the significantly increased risk of pronounced sedation and impairment. This necessitates caution regarding activities that require full mental alertness, such as operating machinery.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information for Chlor-Trimeton (Chlorpheniramine Maleate) defines the overdose profile primarily through significant Central Nervous System (CNS) and Anticholinergic toxicity, which can be life-threatening.

Documented Overdose Presentations

Regulatory documentation outlines two primary, opposite CNS presentations, which can occur sequentially:

  • CNS Excitation: Agitation, nervousness, tremors, hallucinations, and convulsions (seizures). This is documented as more likely to be seen in children and the elderly.
  • CNS Depression: Drowsiness, sedation, disorientation, and progressive coma.

Anticholinergic effects are also prominent, including dry mouth, flushed skin (flushing), fixed and dilated pupils (mydriasis), fever (hyperpyrexia), and urinary retention. Severe, life-threatening outcomes can include respiratory failure, cardiovascular collapse, and deep coma.

Emergency Action Required

Immediate medical attention is required for any suspected overdose of Chlor-Trimeton. Government labeling strictly instructs users to contact a Poison Help line (e.g., 1-800-222-1222 in the U.S.) or emergency services immediately, even if the individual appears well or symptoms are not yet present. Emergency services should be contacted if the person has collapsed, has trouble breathing, or is unresponsive. Management is symptomatic and supportive, focusing on maintaining vital functions and continuous cardiac monitoring.

Therapeutic Uses of Chlor-Trimeton

What Chlor-Trimeton Treats: Main Uses and Benefits

Chlor-Trimeton (chlorpheniramine maleate) is generally used in conditions involving symptoms related to inflammatory or irritative states caused by allergic responses, and is commonly used when short-term symptomatic assistance is needed. This medication is applied across domains where additional symptomatic support is needed and is used for managing manifestations stemming from allergies, hay fever, and the common cold.


Symptom Clusters and Common Uses

Chlor-Trimeton is relevant for easing symptoms associated with allergic rhinitis and is applicable for recurrent manifestations related to perennial environmental triggers. The medication may be part of symptomatic management for conditions presenting with acute episodes that affect the eyes, nose, and skin. It is applied in addressing key symptom clusters such as sneezing, runny nose (rhinorrhea), itchy and watery eyes (allergic conjunctivitis), pruritus (itching), and the localized swelling of hives (urticaria). This supportive relief may assist with improved comfort during periods of heightened symptoms.

In clinical settings, it is commonly used when symptoms intensify and supportive relief is needed, and is applied in clinical settings that involve acute or unstable symptom patterns. This assistance supports general well-being during symptomatic phases.

Quick Fact: Symptomatic Relief
Chlor-Trimeton plays a role in managing symptom clusters like itchy eyes, sneezing, and runny nose in patients experiencing symptomatic flares.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Chlor-Trimeton (chlorpheniramine maleate) is authorized for use in adults and children 12 years and over. Children aged 6 to under 12 years are eligible for use under specific reduced dosage limits. The use of the standard tablet formulation is not established and often labeled as do not use for children under 6 years of age.

Contraindications and Restrictions

The medicine is contraindicated for certain populations as defined in official labeling. These absolute prohibitions include individuals with a known hypersensitivity to chlorpheniramine maleate, or patients who are currently using or have used Monoamine Oxidase Inhibitors (MAOIs) within the last 14 days.

Conditional use (requiring consultation with a health professional before taking) is mandated for individuals with specific pre-existing conditions:

Condition-Based Restriction Special Population Limitation
Glaucoma or raised intra-ocular pressure Older adults (higher susceptibility to effects)
Trouble urinating due to an enlarged prostate Pregnancy or Lactation (ask a health professional before use)
Chronic breathing problem (e.g., emphysema) Severe renal or hepatic impairment (use with caution)

Official regulatory guidance states that use during pregnancy and lactation should be approached with caution and requires consultation prior to taking the medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Chlor-Trimeton (chlorpheniramine maleate) is officially documented by regulatory authorities, focusing on pharmacokinetic and pharmacodynamic interactions.

Documented Interaction Patterns

Interaction Type Interacting Products & Regulatory Statement
Formal Contraindication Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally prohibited. This restriction includes a mandatory 14-day separation period following the discontinuation of MAOI therapy.
Pharmacokinetic (PK) Interaction The medicine is documented to inhibit the metabolism of Phenytoin, resulting in an officially recognized risk of increased plasma concentrations and potential toxicity of Phenytoin.
Pharmacodynamic (PD) Interaction Concurrent use with other Central Nervous System (CNS) depressants (e.g., opioids, sedatives, anxiolytics) or alcohol is stated to result in additive CNS depression.
Pharmacodynamic (PD) Interaction Co-administration with other Anticholinergic Drugs causes an additive antimuscarinic action, which may potentiate adverse effects.

Other Constraints

Other official constraints address the risk of symptom masking when chlorpheniramine is co-administered with ototoxic medications (e.g., cisplatin, vancomycin). Regulatory documentation also notes caution for use in patients with severe hepatic impairment, a consideration tied to the drug’s metabolism and overall exposure.

Mechanism of Action

How Chlor-Trimeton Works: Mechanism of Action

Blocking the Histamine Signal ( H1 Receptor Antagonism)

The primary action of Chlor-Trimeton (chlorpheniramine) is to function as a competitive antagonist at the Histamine-1 ( H1) receptor. It binds directly to the receptor site, thereby blocking the action of the chemical messenger histamine, a key physiological signal. This action results in a reduction of signaling from H1 receptors and dampens histamine-induced physiological responses, such as vasodilation.


Dampening Downstream Physiological Cascades

By preventing the initial activation of H1 receptors, the drug modifies the early molecular steps that normally lead to widespread physiological effects. This mechanistic action influences the H1-mediated cascades that involve processes such as increased vascular permeability and smooth muscle contraction.


Secondary Effect on Cholinergic Pathways

As a first-generation agent, chlorpheniramine also engages mechanisms that affect the muscarinic cholinergic receptors. This anticholinergic activity, which influences signaling by the neurotransmitter acetylcholine, is a secondary mechanistic domain. This effect interferes with cholinergic signaling that typically modulates glandular secretion.

Dosage and Administration Information

Administration Routes and Regimens

Chlor-Trimeton (chlorpheniramine maleate) is approved for administration via the oral route, using immediate-release tablets (4 mg), extended-release forms (8 mg or 12 mg), or liquid formulations. For acute situations where rapid systemic delivery is required, the drug is also approved for parenteral administration via the subcutaneous, intramuscular, or intravenous routes.

The standard adult oral dosing regimen for immediate-release forms is 4 mg per dose, taken every four to six hours as needed, with a maximum daily limit of 24 mg. Parenteral dosing typically ranges from 10 mg to 20 mg per administration, and does not exceed 40 mg within a 24-hour period. The overall use pattern is defined as intermittent or as-needed for temporary symptomatic use.

Procedural and Population Constraints

Specific procedural constraints govern the use of this medicine. Liquid forms are measured using an accurate milliliter measuring device; household utensils are not appropriate. When the intravenous route is selected, the injection is administered slowly over a period of one minute to comply with the established use protocol. Furthermore, a lower initial dose is applied for older adults. If an intermittent dose is missed, the standard approach is skipping the missed dose if it is close to the time for the next dose, and resuming the normal schedule; doses are not doubled.

Recent Clinical Evidence

Research evidence / Overview of studies for Chlor-Trimeton


Evidence for use in Seasonal Allergies (Hay Fever)

Research has examined Chlor-Trimeton in adult populations diagnosed with seasonal allergic rhinitis, a condition characterized by fluctuating or episodic manifestations. These studies were conducted during periods of increased symptom activity, exploring short-term symptom changes. The study designs often involved research examining temporary physiological imbalance, and they monitored outcomes linked to inflammatory or irritative states, such as sneezing, runny nose, and itchy, watery eyes, over defined short-term intervals.

Studies report how symptoms evolved in the observed populations, with research highlighting changes measured during the short-term study period. Findings describe patterns observed in the studies related to physical discomfort. Specifically, patient-reported outcomes describing perceived discomfort were studied, and the evidence contributes to understanding symptom patterns during these acute episodes.


Evidence for use in Perennial Allergies and Other Allergic Conditions

Chlor-Trimeton was evaluated in studies of perennial allergic rhinitis, as well as in other allergic reactions such as urticaria (hives). Research examined this treatment in conditions where symptoms may vary in intensity and may involve periods of heightened symptoms. The studies monitored outcomes reflecting daily functioning or activity level, alongside patient-reported outcomes describing perceived discomfort. The research explored short-term symptom changes over defined time intervals.

Studies contribute to the broader evidence landscape by reporting how symptoms evolved in the observed populations presenting with cycles of stability and flare-ups. Research highlights changes measured during the study period, and findings describe patterns observed related to systemic or functional imbalance. This evidence helps contextualize how patients reported their experience when symptoms became more noticeable.


What is Still Uncertain About Chlor-Trimeton

What remains unclear is the long-term context of these findings. Follow-up durations were limited, meaning there is limited information for long-term outcomes. Evidence quality varies across studies, and comparative evidence with other available options is limited. Subgroup findings are uncertain, and data for certain groups, particularly very young children or older adults with multiple health conditions, remain insufficient. Overall, the research provides context but not individual predictions, and evidence highlights what is known—and what is still uncertain—about this treatment. Certainty remains low for many aspects of the treatment profile beyond short-term use, as sample sizes were modest in many studies.

Key Studies & References

  1. Label: CHLORPHENIRAMINE MALEATE 4 MG - FDA/DailyMed Drug Label
  2. CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria

Frequently Asked Questions (FAQ)

Common questions about Chlor-Trimeton (FAQ)


Q: Is Chlor-Trimeton the same thing as Benadryl?

A: Chlor-Trimeton (chlorpheniramine) and Benadryl (diphenhydramine) are both classified as first-generation antihistamines, meaning they work by blocking histamine. However, regulatory documents suggest diphenhydramine is also approved as a sleep aid and is often associated with more pronounced drowsiness or sedation compared to chlorpheniramine.

Q: What is the difference between Chlor-Trimeton and Claritin?

A: According to official product information, Chlor-Trimeton is a first-generation antihistamine, while Claritin (loratadine) is a second-generation antihistamine. First-generation drugs are generally associated with a higher potential for drowsiness or sedation, compared to second-generation drugs like Claritin.

Q: Can Chlor-Trimeton make you feel dizzy or lightheaded?

A: Yes, regulatory documents list dizziness as a common adverse reaction. Official safety documents also mention lightheadedness as a potential effect, especially when the active ingredient is used in combination products. This potential for dizziness or lightheadedness is why official labeling often advises caution.

Q: Does Chlor-Trimeton cause an upset stomach?

A: Official safety data lists dry mouth and constipation as common side effects affecting the gastrointestinal system. While 'upset stomach' is not a specific official term, general discomfort such as nausea and vomiting has been noted in the safety reports for products containing the active ingredient.

Q: Can you take Chlor-Trimeton with common pain relievers like ibuprofen?

A: Regulatory documents do not list an official contraindication or major interaction specifically for non-opioid pain relievers like ibuprofen. The primary interaction warnings documented in the label relate to Central Nervous System (CNS) depressants, alcohol, Monoamine Oxidase Inhibitors (MAOIs), and other anticholinergic drugs.

Q: Is it okay to take Chlor-Trimeton if I have high blood pressure?

A: The official labeling for the product and its common cold/flu combinations indicates that patients with high blood pressure (hypertension) are advised to consult a health professional before taking the medicine. This is a common precaution listed in the Warnings and Precautions section.

Q: Can Chlor-Trimeton be taken with cough and cold syrups?

A: Since the active ingredient in Chlor-Trimeton is often included in cough and cold syrups, it is important to check the labels of all medicines. Official guidance notes that patients should review product labels to avoid accidentally taking multiple sources of antihistamines or CNS depressants, which could increase the risk of side effects like drowsiness.

Q: Why is the drug often combined with other ingredients in cold medicines?

A: Chlor-Trimeton (chlorpheniramine) is commonly combined with other drugs, such as decongestants or pain relievers, in cold medicines. Regulatory documents list its indications for temporary relief of allergy symptoms like runny nose and sneezing, which are common symptoms of the cold and flu.

Q: Does Chlor-Trimeton help with indoor or outdoor allergies better?

A: Clinical study overviews indicate that the medicine is used to treat symptoms of both seasonal allergic rhinitis (often outdoor, like hay fever) and perennial allergic rhinitis (often indoor, like dust mites). Studies show the medicine is used for symptom relief in both indoor and outdoor allergy contexts.

Q: Is it possible for Chlor-Trimeton to make anxiety worse?

A: Official safety information notes that side effects may include effects on the central nervous system such as restlessness, excitement, and nervousness. Additionally, regulatory guidance warns that co-use with other CNS depressants may worsen effects.

Q: Why is Chlor-Trimeton sometimes prescribed for sleeplessness?

A: Chlor-Trimeton is a first-generation antihistamine, and official safety information lists drowsiness and sedation as very common side effects. While not an official approved indication for sleep, the sedative effect is a known property of the drug class and is acknowledged in public health documents.

Q: What does the 'maleate' part of chlorpheniramine maleate mean?

A: The 'maleate' part refers to maleic acid, which is chemically bonded to the active drug, chlorpheniramine, to create a salt. This chemical modification is a standard method used to increase the drug's stability and solubility for the final product.

Q: Do other common OTC drugs contain the same active ingredient as Chlor-Trimeton?

A: Yes, the active ingredient chlorpheniramine maleate is widely used in many other over-the-counter multi-symptom cold and flu combination products. This highlights the need to check product labels to avoid accidental exposure to multiple sources of the same active ingredient.

Q: What are the signs that Chlor-Trimeton might not be working for my allergies?

A: Official regulatory guidance advises seeking consultation if allergy symptoms do not improve within 7 days of taking the medicine, or if symptoms are accompanied by a fever. This lack of improvement is a condition under which official guidance suggests consulting a health professional.

Q: Does Chlor-Trimeton lose potency after the expiration date?

A: Official storage instructions focus on maintaining product stability and safety by storing it properly. Regulatory documents do not support the safety or effectiveness of drugs used past the expiration date printed on the label.

Q: Is there a link between Chlor-Trimeton and restlessness?

A: Yes, official regulatory documents list restlessness and excitement as documented adverse reactions. This effect is often noted as a paradoxical reaction because it can be stimulating, which is the opposite of the typical sedating effect, particularly in some pediatric patients.

Q: Can Chlor-Trimeton cause confusion in elderly patients?

A: Yes, official safety notes specifically state that older adults are generally more susceptible to Central Nervous System (CNS) side effects. These effects include pronounced sedation, dizziness, and confusion.

Q: How is Chlor-Trimeton eliminated from the body?

A: Pharmacokinetic data indicates that the drug is primarily metabolized (broken down) in the liver and is then mostly eliminated from the body via the kidneys (urinary excretion).

Q: Is it normal to feel a bit 'foggy' on Chlor-Trimeton?

A: While 'foggy' is a user term, official documents list drowsiness, sedation, and confusion as common CNS-related side effects. These documented effects may align with the feeling of being mentally impaired or 'foggy.'

Q: Can taking Chlor-Trimeton affect the results of an allergy skin test?

A: Yes, regulatory documents generally state that antihistamines may prevent or diminish positive reactions to allergy skin tests. Official guidance typically suggests that the medicine should be discontinued for a period of time before such testing is performed.

Q: Are there any food restrictions when taking Chlor-Trimeton?

A: Official drug labels and public health documents typically list no specific food restrictions. The main lifestyle warning is to avoid alcoholic beverages due to the significantly increased risk of pronounced sedation and impairment.

Q: Is there a risk of dependency with Chlor-Trimeton?

A: Regulatory documents do not list dependency as a primary risk for standard use. However, the active ingredient belongs to a class of drugs (antihistamines) whose misuse has been associated with reports of psychological dependence in some medical literature.

Q: Does Chlor-Trimeton interfere with birth control pills?

A: Regulatory documents for Chlor-Trimeton do not list oral contraceptives (birth control pills) as a known interaction. The documented warnings relate to other Central Nervous System-acting drugs, MAOIs, and alcohol.

Q: Is Chlor-Trimeton known to affect heart rate?

A: Yes, tachycardia (a fast or irregular heartbeat) is listed as a documented, though rare, adverse reaction in the product’s safety information. The labeling advises that patients with pre-existing heart disease should consult a health professional before taking the medicine.

Q: Does Chlor-Trimeton have a history of being used for cold symptoms, not just allergies?

A: Yes, in addition to being approved for allergies, the active ingredient in Chlor-Trimeton is widely approved by regulatory agencies as a component in combination products to relieve symptoms associated with the common cold, such as runny nose and sneezing.

Q: How quickly does Chlor-Trimeton start working for allergy symptoms?

A: Authoritative reviews confirm that Chlor-Trimeton is clinically recognized for its rapid onset of action in providing relief. While the exact time frame varies by individual, it is expected that the drug begins to exert its effect soon after a dose is taken.

Q: How long do the effects of a single dose of Chlor-Trimeton usually last?

A: The standard dosing instructions advise taking the medication every four to six hours as needed for symptom relief. This timing reflects the expected duration of symptom relief provided by the immediate-release formulation.

Q: What should I do if a side effect from Chlor-Trimeton is bothering me?

A: Official guidance advises seeking medical consultation if allergy symptoms do not improve or if any side effect becomes severe or bothersome. The safety profile notes that while some side effects are common, serious adverse reactions are rare and should be discussed with a health professional.

Q: What happens if I forget to take a dose of Chlor-Trimeton?

A: Official administration instructions advise skipping the missed dose if it is close to the time for the next scheduled dose. Administration instructions advise against doubling the dose to make up for a missed one, and recommend resuming the normal schedule.

Q: Is there a non-drowsy version of Chlor-Trimeton available?

A: The active ingredient in Chlor-Trimeton (chlorpheniramine) is a first-generation antihistamine, and drowsiness and sedation are listed as very common side effects. Products based on its mechanism are typically associated with these sedating effects.

Q: Are there any long-term effects associated with regular use of Chlor-Trimeton?

A: Official research overviews indicate that most clinical studies on this drug have had limited follow-up durations. This means there is limited official information available regarding the outcomes or effects associated with very long-term, continuous use.

Q: Can someone with asthma take Chlor-Trimeton?

A: Regulatory documents list a chronic breathing problem (such as emphysema or chronic obstructive pulmonary disease) as a pre-existing condition that requires conditional use. Patients with asthma are generally advised to discuss the use of this medicine with a health professional before taking it.

Q: What's the difference between the 4 mg and 8 mg Chlor-Trimeton tablets?

A: According to administration documents, the 4 mg tablet is typically an immediate-release form, designed to work quickly. The 8 mg and 12 mg tablets are usually extended-release forms, designed to release the medication over a longer period, which can provide relief for an extended duration.


How should Chlor-Trimeton be stored and disposed of?

Storage and Disposal Conditions for Chlor-Trimeton (Chlorpheniramine Maleate)

The official storage and handling requirements for Chlor-Trimeton are based on maintaining product stability and safety, as outlined by regulatory agencies.

Storage Requirements

Chlorpheniramine maleate preparations must be stored at controlled room temperature, specifically between 20°C to 25°C (68°F to 77°F). The product must be protected from excessive moisture and kept in the container it was dispensed in, with the container tightly closed.

Child Safety: It is mandatory to Keep out of reach of children.


Disposal Instructions

Disposal of unused or expired Chlor-Trimeton must be performed in accordance with local/national regulations. The active substance is generally restricted from contaminating water sources; therefore, it must not be allowed to enter sewers, surface water, or ground water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chlor-Trimeton found in:

A-Z Index: